Scarica l'app Stockscreener
2.76
18.97%
0.44
Okyo Pharma Limited Borsa (OKYO) Ultime notizie
Dividend Watch: Will OKYO Pharma Limited stock benefit from green energy trendsMarket Volume Report & Daily Profit Maximizing Tips - ulpravda.ru
Will OKYO Pharma Limited stock benefit from green energy trendsQuarterly Earnings Summary & Weekly Hot Stock Watchlists - ulpravda.ru
Can OKYO Pharma Limited stock beat analyst upgradesJuly 2025 Patterns & Real-Time Buy Signal Alerts - ulpravda.ru
Will OKYO Pharma Limited stock outperform growth indexesStop Loss & Detailed Earnings Play Strategies - ulpravda.ru
Will OKYO Pharma Limited stock benefit from automationEarnings Recap Summary & Weekly Setup with ROI Potential - ulpravda.ru
Will OKYO Pharma Limited stock recover faster than marketJuly 2025 WrapUp & Smart Money Movement Tracker - ulpravda.ru
Can OKYO Pharma Limited stock resist market sell offsQuarterly Earnings Summary & Fast Entry Momentum Alerts - ulpravda.ru
Entry Recap: Can OKYO Pharma Limited stock beat analyst upgradesJuly 2025 PostEarnings & Fast Gain Swing Trade Alerts - ulpravda.ru
What Wall Street predicts for OKYO Pharma Limited stock priceQuarterly Trade Review & Weekly Top Stock Performers List - ulpravda.ru
Is OKYO Pharma Limited stock trading at a premium valuationTechnical Pattern Recognition & Identify Winning Stocks - ulpravda.ru
H.C. Wainwright reiterates Buy rating on OKYO Pharma stock at $7 target By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Buy rating on OKYO Pharma stock at $7 target - Investing.com
OKYO Pharma appoints Robert Dempsey as new CEO By Investing.com - Investing.com Nigeria
OKYO Pharma: Strengthened Leadership and Promising Urcosimod Data Support Reiterated Buy Rating and Upside Potential - TipRanks
OKYO Pharma appoints Ophthalmology veteran Robert Dempsey as new CEO - Proactive financial news
OKYO Pharma names ophthalmology veteran Robert Dempsey as CEO - Proactive financial news
OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer - BioSpace
OKYO Pharma names Robert J. Dempsey as chief executive officer By Investing.com - Investing.com Australia
OKYO Pharma names Robert J. Dempsey as chief executive officer - Investing.com
OKYO Pharma Names Ophthalmology Veteran Robert J. Dempsey as CEO to Drive Next Growth Phase - TipRanks
OKYO Pharma names ophthalmology veteran Robert J Dempsey as CEO to drive next growth phase - MSN
Is Alico Inc stock a smart buy before Fed meetingRisk Management & Fast Exit and Entry Trade Guides - moha.gov.vn
Will OKYO Pharma Limited stock remain a Wall Street favoriteTrendline Breakouts & Free High Yield Portfolio Picks - bollywoodhelpline.com
Technical Analysis: What dividend safety score for OKYO Pharma Limited stockMarket Activity Recap & Fast Moving Stock Trade Plans - moha.gov.vn
OKYO Pharma reports positive phase 2 results for Urcosimod in neuropathic corneal pain - MSN
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Short Interest Update - MarketBeat
Will OKYO Pharma Limited stock maintain dividend yieldJuly 2025 Catalysts & Trade Opportunity Analysis Reports - Улправда
Volatility Watch: How OKYO Pharma Limited OK11 stock gains from tech spendingJuly 2025 Price Swings & Verified High Yield Trade Plans - moha.gov.vn
Bank Watch: What Wall Street predicts for OKYO Pharma Limited stock priceJuly 2025 Levels & Daily Chart Pattern Signals - Улправда
Will OKYO Pharma Limited (OK11) stock hit analyst forecastsMarket Trend Review & Weekly High Return Stock Opportunities - Улправда
Is OKYO Pharma Limited stock affected by interest rate hikesTake Profit & AI Powered Market Trend Analysis - Улправда
Will OKYO Pharma Limited stock see PE expansionJuly 2025 Reactions & Stock Market Timing Techniques - Улправда
Small cap wrap: Gunnison Copper, OKYO Pharma, Abacus Global Management… - Proactive Investors
Is OKYO Pharma Limited (OK11) stock suitable for passive index fundsJuly 2025 EndofMonth & Weekly High Return Stock Forecasts - Улправда
OKYO Pharma management to ring Nasdaq opening bell in New York - Investing.com Australia
Pullback Watch: Why retail investors pile into OKYO Pharma Limited stock2025 Market WrapUp & AI Driven Stock Movement Reports - DonanımHaber
OKYO Pharma Ltd Rings the Nasdaq Stock Market Opening Bell - Nasdaq
OKYO Pharma Ltd Rings the Opening Bell - Nasdaq
OKYO Pharma has dry eyes as a lucrative prize in its sights - Proactive Investors
OKYO Pharma management to ring Nasdaq opening bell in New York By Investing.com - Investing.com South Africa
OKYO Pharma Rings Nasdaq Opening Bell as Urcosimod Advances After Positive Phase 2 NCP Data - TipRanks
OKYO Pharma to Ring the Opening Bell at Nasdaq - The Manila Times
How OKYO Pharma Limited (OK11) stock gains from tech spendingMarket Performance Summary & Expert Verified Stock Movement Alerts - DonanımHaber
Why OKYO Pharma Limited stock is rated strong buy2025 Growth vs Value & Comprehensive Market Scan Insights - DonanımHaber
Will OKYO Pharma Limited stock deliver long term returnsBreakout Watch & High Conviction Investment Ideas - Улправда
Is OKYO Pharma Limited stock positioned for digital transformation2025 Retail Activity & Precise Swing Trade Alerts - Улправда
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):